Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial (NCT07567040)
🩺 Plain-English Summary (8th-Grade Level)
The aims of this clinical trial will test whether or not the onset of nearsightedness is delayed in a group of children randomized to nightly drops in 0.05% atropine in both eyes, in comparison to children who receiving nightly placebo drops in both eyes. The primary outcome is the two-year cumulative incidence of nearsightedness. The second aim of this project will determine whether atropine is associated with slower eye growth in children receiving nightly drops of atropine versus placebo.
Who can join: Review the eligibility criteria below.
Location: University of Alabama School of Optometry — Birmingham, Alabama
Age range: 6 Years to 11 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (13 Sites)
- University of Alabama School of Optometry — Birmingham, Alabama
- University of California, Berkeley, School of Optometry — Berkeley, California
- Southern California College of Optometry at Marshall B. Ketchum University — Fullerton, California
- Stanford University — Palo Alto, California
- Illinois College of Optometry — Chicago, Illinois
- Indiana University — Bloomington, Indiana
- New England College of Optometry — Boston, Massachusetts
- State University of New York College of Optometry — New York, New York
- Case Western Reserve Department of Ophthalmology — Cleveland, Ohio
- The Ohio State University College of Optometry — Columbus, Ohio
- Pennsylvania College of Optometry at Drexel University — Elkins Park, Pennsylvania
- Southern College of Optometry — Memphis, Tennessee
- University of Houston College of Optometry — Houston, Texas
📞 Contact the Study Coordinator
Phone: (614) 247-7321
Email: jordan.646@osu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Myopia
- LASIK Using Contoura With Phorcides vs. iDesign — San Antonio, Texas
- Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness — Waterloo, Ontario
- Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial — Fresno, California
- Acuity 200™ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear — Mission Viejo, California
- Visual Performance of Center Distance Daily Disposable Multifocal Lenses — Columbus, Ohio
- MiSight 1 Day Safety Post-Approval Study — Gilbert, Arizona
Explore by condition: All Myopia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.